nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—RET—autonomic nervous system—conduct disorder	0.139	0.356	CbGeAlD
Regorafenib—DDR2—brain—conduct disorder	0.0249	0.064	CbGeAlD
Regorafenib—MAPK11—brain—conduct disorder	0.0237	0.0607	CbGeAlD
Regorafenib—BRAF—brain—conduct disorder	0.0176	0.0453	CbGeAlD
Regorafenib—EPHX2—brain—conduct disorder	0.0169	0.0433	CbGeAlD
Regorafenib—FLT4—brain—conduct disorder	0.0152	0.039	CbGeAlD
Regorafenib—FGFR1—brain—conduct disorder	0.015	0.0385	CbGeAlD
Regorafenib—RET—brain—conduct disorder	0.0134	0.0344	CbGeAlD
Regorafenib—FGFR2—brain—conduct disorder	0.0127	0.0327	CbGeAlD
Regorafenib—EPHA2—brain—conduct disorder	0.0125	0.0322	CbGeAlD
Regorafenib—TEK—brain—conduct disorder	0.0122	0.0314	CbGeAlD
Regorafenib—FLT1—brain—conduct disorder	0.0118	0.0303	CbGeAlD
Regorafenib—RAF1—brain—conduct disorder	0.0117	0.0302	CbGeAlD
Regorafenib—PDGFRA—brain—conduct disorder	0.0111	0.0284	CbGeAlD
Regorafenib—KDR—brain—conduct disorder	0.00999	0.0256	CbGeAlD
Regorafenib—KIT—brain—conduct disorder	0.00885	0.0227	CbGeAlD
Regorafenib—PDGFRB—brain—conduct disorder	0.00865	0.0222	CbGeAlD
Regorafenib—ABL1—brain—conduct disorder	0.00771	0.0198	CbGeAlD
Regorafenib—CYP2C8—brain—conduct disorder	0.005	0.0128	CbGeAlD
Regorafenib—ABCG2—brain—conduct disorder	0.00486	0.0125	CbGeAlD
Regorafenib—CYP2B6—brain—conduct disorder	0.00448	0.0115	CbGeAlD
Regorafenib—ABCB1—brain—conduct disorder	0.0024	0.00615	CbGeAlD
Regorafenib—BRAF—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00219	0.00358	CbGpPWpGaD
Regorafenib—ABL1—p53 pathway—EP300—conduct disorder	0.00215	0.00353	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—MB21D1—conduct disorder	0.00213	0.00349	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—CGA—conduct disorder	0.00211	0.00346	CbGpPWpGaD
Regorafenib—PDGFRB—Validated targets of C-MYC transcriptional repression—EP300—conduct disorder	0.0021	0.00343	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—POLR3A—conduct disorder	0.00209	0.00343	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—POLR3A—conduct disorder	0.00206	0.00337	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00203	0.00332	CbGpPWpGaD
Regorafenib—UGT1A1—Biological oxidations—COMT—conduct disorder	0.00201	0.00329	CbGpPWpGaD
Regorafenib—UGT1A9—Biological oxidations—COMT—conduct disorder	0.00201	0.00329	CbGpPWpGaD
Regorafenib—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.00199	0.00326	CbGpPWpGaD
Regorafenib—UGT1A9—Biological oxidations—MAOA—conduct disorder	0.00199	0.00326	CbGpPWpGaD
Regorafenib—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.00198	0.00324	CbGpPWpGaD
Regorafenib—UGT1A9—Metapathway biotransformation—COMT—conduct disorder	0.00198	0.00324	CbGpPWpGaD
Regorafenib—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00197	0.00323	CbGpPWpGaD
Regorafenib—RAF1—Kit receptor signaling pathway—EP300—conduct disorder	0.00197	0.00323	CbGpPWpGaD
Regorafenib—ABL1—Regulation of retinoblastoma protein—EP300—conduct disorder	0.00197	0.00322	CbGpPWpGaD
Regorafenib—KIT—C-MYB transcription factor network—EP300—conduct disorder	0.00195	0.0032	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—POLR3A—conduct disorder	0.00195	0.0032	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—POLR3A—conduct disorder	0.00195	0.00319	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—WASF1—conduct disorder	0.00192	0.00314	CbGpPWpGaD
Regorafenib—BRAF—Neuronal System—COMT—conduct disorder	0.00192	0.00314	CbGpPWpGaD
Regorafenib—BRAF—Neuronal System—MAOA—conduct disorder	0.0019	0.00312	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00189	0.0031	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00188	0.00309	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—MB21D1—conduct disorder	0.00181	0.00296	CbGpPWpGaD
Regorafenib—RAF1—Regulation of retinoblastoma protein—EP300—conduct disorder	0.0018	0.00295	CbGpPWpGaD
Regorafenib—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00176	0.00289	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—WASF1—conduct disorder	0.00176	0.00289	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—POLR3A—conduct disorder	0.00175	0.00287	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—WASF1—conduct disorder	0.00173	0.00283	CbGpPWpGaD
Regorafenib—RAF1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00173	0.00283	CbGpPWpGaD
Regorafenib—RAF1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00172	0.00281	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—POLR3A—conduct disorder	0.00171	0.0028	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00171	0.0028	CbGpPWpGaD
Regorafenib—ABL1—p73 transcription factor network—EP300—conduct disorder	0.0017	0.00279	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.0017	0.00278	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—WASF1—conduct disorder	0.00169	0.00277	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—MB21D1—conduct disorder	0.00166	0.00272	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—WASF1—conduct disorder	0.00164	0.00269	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—WASF1—conduct disorder	0.00164	0.00268	CbGpPWpGaD
Regorafenib—KIT—Immune System—MB21D1—conduct disorder	0.00163	0.00267	CbGpPWpGaD
Regorafenib—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00161	0.00263	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—CGA—conduct disorder	0.00158	0.00258	CbGpPWpGaD
Regorafenib—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00157	0.00257	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—POLR3A—conduct disorder	0.00156	0.00256	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—MB21D1—conduct disorder	0.00155	0.00254	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—MB21D1—conduct disorder	0.00154	0.00253	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00151	0.00248	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00148	0.00242	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—WASF1—conduct disorder	0.00148	0.00242	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—WASF1—conduct disorder	0.00144	0.00236	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—MB21D1—conduct disorder	0.00139	0.00228	CbGpPWpGaD
Regorafenib—ABL1—Cell Cycle—EP300—conduct disorder	0.00139	0.00228	CbGpPWpGaD
Regorafenib—NTRK1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00138	0.00226	CbGpPWpGaD
Regorafenib—ABL1—Immune System—MB21D1—conduct disorder	0.00136	0.00222	CbGpPWpGaD
Regorafenib—BRAF—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00134	0.0022	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—POLR3A—conduct disorder	0.00133	0.00218	CbGpPWpGaD
Regorafenib—NTRK1—Circadian rythm related genes—EP300—conduct disorder	0.00133	0.00217	CbGpPWpGaD
Regorafenib—RAF1—Neuronal System—COMT—conduct disorder	0.00132	0.00217	CbGpPWpGaD
Regorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00132	0.00216	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—POLR3A—conduct disorder	0.00132	0.00216	CbGpPWpGaD
Regorafenib—RAF1—Neuronal System—MAOA—conduct disorder	0.00132	0.00216	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—WASF1—conduct disorder	0.00132	0.00215	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00129	0.00211	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—WASF1—conduct disorder	0.00126	0.00207	CbGpPWpGaD
Regorafenib—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00125	0.00204	CbGpPWpGaD
Regorafenib—RAF1—Immune System—MB21D1—conduct disorder	0.00124	0.00203	CbGpPWpGaD
Regorafenib—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00124	0.00203	CbGpPWpGaD
Regorafenib—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00123	0.00202	CbGpPWpGaD
Regorafenib—UGT1A9—PPARA activates gene expression—EP300—conduct disorder	0.00123	0.00201	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—POLR3A—conduct disorder	0.00122	0.002	CbGpPWpGaD
Regorafenib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.0012	0.00197	CbGpPWpGaD
Regorafenib—KIT—Immune System—POLR3A—conduct disorder	0.0012	0.00196	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—DRD4—conduct disorder	0.00118	0.00194	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—COMT—conduct disorder	0.00116	0.0019	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—MAOA—conduct disorder	0.00115	0.00189	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—POLR3A—conduct disorder	0.00114	0.00186	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—POLR3A—conduct disorder	0.00113	0.00186	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—WASF1—conduct disorder	0.00112	0.00183	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00112	0.00183	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CGA—conduct disorder	0.00111	0.00182	CbGpPWpGaD
Regorafenib—ABL1—Factors involved in megakaryocyte development and platelet production—EP300—conduct disorder	0.0011	0.00181	CbGpPWpGaD
Regorafenib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00106	0.00174	CbGpPWpGaD
Regorafenib—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00106	0.00173	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CGA—conduct disorder	0.00105	0.00172	CbGpPWpGaD
Regorafenib—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00105	0.00172	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CGA—conduct disorder	0.00105	0.00171	CbGpPWpGaD
Regorafenib—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00104	0.00171	CbGpPWpGaD
Regorafenib—RAF1—TGF-beta Signaling Pathway—EP300—conduct disorder	0.00103	0.00169	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—WASF1—conduct disorder	0.00103	0.00168	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—POLR3A—conduct disorder	0.00102	0.00167	CbGpPWpGaD
Regorafenib—ABL1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00102	0.00166	CbGpPWpGaD
Regorafenib—KIT—Immune System—WASF1—conduct disorder	0.00101	0.00165	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—EP300—conduct disorder	0.001	0.00164	CbGpPWpGaD
Regorafenib—ABL1—Immune System—POLR3A—conduct disorder	0.000995	0.00163	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000961	0.00157	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000958	0.00157	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—WASF1—conduct disorder	0.000957	0.00157	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—WASF1—conduct disorder	0.000954	0.00156	CbGpPWpGaD
Regorafenib—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000943	0.00154	CbGpPWpGaD
Regorafenib—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000936	0.00153	CbGpPWpGaD
Regorafenib—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00093	0.00152	CbGpPWpGaD
Regorafenib—RAF1—Immune System—POLR3A—conduct disorder	0.00091	0.00149	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CGA—conduct disorder	0.000902	0.00148	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000898	0.00147	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CGA—conduct disorder	0.000893	0.00146	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—WASF1—conduct disorder	0.000889	0.00146	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—DRD4—conduct disorder	0.000883	0.00145	CbGpPWpGaD
Regorafenib—MAPK11—Cellular responses to stress—EP300—conduct disorder	0.000866	0.00142	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—EP300—conduct disorder	0.000866	0.00142	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—WASF1—conduct disorder	0.00086	0.00141	CbGpPWpGaD
Regorafenib—CYP2C9—Biological oxidations—COMT—conduct disorder	0.000859	0.00141	CbGpPWpGaD
Regorafenib—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.000853	0.0014	CbGpPWpGaD
Regorafenib—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000849	0.00139	CbGpPWpGaD
Regorafenib—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.000848	0.00139	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000841	0.00138	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—WASF1—conduct disorder	0.00084	0.00138	CbGpPWpGaD
Regorafenib—ABL1—Immune System—WASF1—conduct disorder	0.000838	0.00137	CbGpPWpGaD
Regorafenib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.000829	0.00136	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CGA—conduct disorder	0.000828	0.00136	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CGA—conduct disorder	0.000813	0.00133	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000802	0.00131	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—HTR2A—conduct disorder	0.000772	0.00126	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CGA—conduct disorder	0.000772	0.00126	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CGA—conduct disorder	0.00077	0.00126	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000769	0.00126	CbGpPWpGaD
Regorafenib—RAF1—Immune System—WASF1—conduct disorder	0.000766	0.00126	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CGA—conduct disorder	0.00076	0.00124	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CGA—conduct disorder	0.00076	0.00124	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000731	0.0012	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—WASF1—conduct disorder	0.000723	0.00118	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—WASF1—conduct disorder	0.000716	0.00117	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000698	0.00114	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CGA—conduct disorder	0.000693	0.00114	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—WASF1—conduct disorder	0.000664	0.00109	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—WASF1—conduct disorder	0.000652	0.00107	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CGA—conduct disorder	0.000645	0.00106	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—DRD4—conduct disorder	0.000621	0.00102	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—WASF1—conduct disorder	0.000618	0.00101	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CGA—conduct disorder	0.000618	0.00101	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—WASF1—conduct disorder	0.000617	0.00101	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—EP300—conduct disorder	0.00061	0.001	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—DRD4—conduct disorder	0.000587	0.000962	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—DRD4—conduct disorder	0.000586	0.00096	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—HTR2A—conduct disorder	0.000576	0.000943	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000567	0.000929	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000563	0.000922	CbGpPWpGaD
Regorafenib—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000559	0.000916	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—WASF1—conduct disorder	0.000556	0.00091	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—EP300—conduct disorder	0.000525	0.00086	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—DRD4—conduct disorder	0.000505	0.000827	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—DRD4—conduct disorder	0.0005	0.00082	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—EP300—conduct disorder	0.000497	0.000814	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—WASF1—conduct disorder	0.000495	0.000811	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CGA—conduct disorder	0.000473	0.000774	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—DRD4—conduct disorder	0.000464	0.00076	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—EP300—conduct disorder	0.000464	0.000759	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—DRD4—conduct disorder	0.000455	0.000746	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—EP300—conduct disorder	0.000449	0.000736	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—DRD4—conduct disorder	0.000432	0.000708	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—DRD4—conduct disorder	0.000431	0.000706	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—EP300—conduct disorder	0.000426	0.000697	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—EP300—conduct disorder	0.000418	0.000685	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—EP300—conduct disorder	0.000409	0.00067	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HTR2A—conduct disorder	0.000405	0.000664	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CGA—conduct disorder	0.0004	0.000655	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—EP300—conduct disorder	0.000397	0.00065	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—EP300—conduct disorder	0.000396	0.000648	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—EP300—conduct disorder	0.000393	0.000644	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD4—conduct disorder	0.000388	0.000636	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—EP300—conduct disorder	0.000386	0.000632	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HTR2A—conduct disorder	0.000383	0.000628	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HTR2A—conduct disorder	0.000382	0.000626	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000363	0.000594	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—EP300—conduct disorder	0.00036	0.000589	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CGA—conduct disorder	0.000357	0.000585	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—EP300—conduct disorder	0.000356	0.000584	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—EP300—conduct disorder	0.000353	0.000578	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CGA—conduct disorder	0.000349	0.000571	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—EP300—conduct disorder	0.000347	0.000569	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD4—conduct disorder	0.000346	0.000567	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—COMT—conduct disorder	0.000343	0.000562	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—COMT—conduct disorder	0.000343	0.000562	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—MAOA—conduct disorder	0.000341	0.000558	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—MAOA—conduct disorder	0.000341	0.000558	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00033	0.000541	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR2A—conduct disorder	0.000329	0.00054	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR2A—conduct disorder	0.000326	0.000535	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CGA—conduct disorder	0.000326	0.000533	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—EP300—conduct disorder	0.000318	0.00052	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—EP300—conduct disorder	0.000305	0.0005	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR2A—conduct disorder	0.000303	0.000496	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR2A—conduct disorder	0.000297	0.000487	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—COMT—conduct disorder	0.000291	0.000477	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—MAOA—conduct disorder	0.000289	0.000473	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR2A—conduct disorder	0.000282	0.000462	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR2A—conduct disorder	0.000281	0.000461	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—EP300—conduct disorder	0.00027	0.000442	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR2A—conduct disorder	0.000253	0.000415	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—EP300—conduct disorder	0.000248	0.000406	CbGpPWpGaD
Regorafenib—BRAF—Disease—EP300—conduct disorder	0.000247	0.000405	CbGpPWpGaD
Regorafenib—KIT—Immune System—EP300—conduct disorder	0.000243	0.000399	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—EP300—conduct disorder	0.000231	0.000379	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—EP300—conduct disorder	0.00023	0.000378	CbGpPWpGaD
Regorafenib—FGFR2—Disease—EP300—conduct disorder	0.000229	0.000375	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR2A—conduct disorder	0.000226	0.00037	CbGpPWpGaD
Regorafenib—KIT—Disease—EP300—conduct disorder	0.000225	0.000368	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—EP300—conduct disorder	0.000215	0.000352	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CGA—conduct disorder	0.000215	0.000352	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—COMT—conduct disorder	0.000213	0.000349	CbGpPWpGaD
Regorafenib—FGFR1—Disease—EP300—conduct disorder	0.000213	0.000349	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—EP300—conduct disorder	0.000213	0.000349	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—MAOA—conduct disorder	0.000212	0.000347	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—EP300—conduct disorder	0.000208	0.00034	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—EP300—conduct disorder	0.000203	0.000333	CbGpPWpGaD
Regorafenib—ABL1—Immune System—EP300—conduct disorder	0.000202	0.000331	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—EP300—conduct disorder	0.000192	0.000314	CbGpPWpGaD
Regorafenib—RAF1—Immune System—EP300—conduct disorder	0.000185	0.000303	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—COMT—conduct disorder	0.000181	0.000296	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MAOA—conduct disorder	0.000179	0.000294	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—EP300—conduct disorder	0.000175	0.000286	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000174	0.000285	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—EP300—conduct disorder	0.000173	0.000283	CbGpPWpGaD
Regorafenib—RAF1—Disease—EP300—conduct disorder	0.000171	0.00028	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—COMT—conduct disorder	0.000161	0.000264	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—EP300—conduct disorder	0.00016	0.000263	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MAOA—conduct disorder	0.00016	0.000262	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—EP300—conduct disorder	0.000157	0.000258	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—COMT—conduct disorder	0.000157	0.000258	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MAOA—conduct disorder	0.000156	0.000256	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000155	0.000254	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—EP300—conduct disorder	0.000149	0.000245	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—EP300—conduct disorder	0.000149	0.000244	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—EP300—conduct disorder	0.000147	0.000241	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—EP300—conduct disorder	0.000147	0.000241	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—COMT—conduct disorder	0.000147	0.000241	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MAOA—conduct disorder	0.000146	0.000239	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000142	0.000232	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—EP300—conduct disorder	0.000134	0.00022	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—EP300—conduct disorder	0.000125	0.000204	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—EP300—conduct disorder	0.00012	0.000196	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—COMT—conduct disorder	9.69e-05	0.000159	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MAOA—conduct disorder	9.63e-05	0.000158	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—EP300—conduct disorder	9.15e-05	0.00015	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—EP300—conduct disorder	7.74e-05	0.000127	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—EP300—conduct disorder	6.91e-05	0.000113	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—EP300—conduct disorder	6.75e-05	0.000111	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—EP300—conduct disorder	6.3e-05	0.000103	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—EP300—conduct disorder	4.16e-05	6.81e-05	CbGpPWpGaD
